Creative Biolabs-Immuno-oncology

Anti-CSPG4 (clone 2E2E5L.2E8Ps) SynExpress E1-TG-NF-X Modified CD8+ T cells (CAT#: ITS-1224-CR883)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CSPG4 (clone 2E2E5L.2E8Ps). We employs the Lentivirus (EF1α-TurboGFP-NF-κB-XbaI) vector components and the SynExpress system of the Multiple base pair Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CSPG4
Clone
2E2E5L.2E8Ps
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
NF-κB
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Multiple base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.94
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.